Original InvestigationCardiac Genetic Predisposition in Sudden Infant Death Syndrome
Central Illustration
Key Words
Abbreviations and Acronyms
Cited by (0)
This work was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health (grant no. R01HD042569 to Dr. Ackerman) and by the British Heart Foundation (BHF Clinical Research Training Fellowship FS/13/78/30520 to Drs. Wong and Behr). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Mr. Tester is supported by the Mayo Clinic Windland Smith Rice Comprehensive Sudden Cardiac Death Program. Dr. Wong is supported by additional funds from Biotronik and Cardiac Risk in the Young. Dr. Behr is supported by the Higher Education Funding Council for England; is a consultant for Medtronic; has received research funding from Biotronik; and has received funds from The Robert Lancaster Memorial Fund sponsored by McColl's RG Ltd. Dr. Ackerman is a consultant for Audentes Therapeutics, Boston Scientific, Gilead Sciences, Invitae, Medtronic, MyoKardia, and St. Jude Medical; is supported by the Mayo Clinic Windland Smith Rice Comprehensive Sudden Cardiac Death Program; and the Mayo Clinic have an equity- or royalty-based relationship with AliveCor, Blue Ox Health, and StemoniX, although none of these entities were involved in this study in any way. Dr. Simpson has a part-time contract of service with Genomics. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Mr. Tester and Dr. Wong contributed equally to this work and are joint first authors. Drs. Simpson, Behr, and Ackerman contributed equally to this work and are joint senior authors.